Keryx Biopharmaceuticals, Inc. News
Why 2018 will be better for biotech deals than 2017
Analysts see a year of robust deal action ahead due in part to clarity from a tax standpoint.
Biotech premarket movers: Cytokinetics, Artana Therapeutics, Bluebird
Shares of late-stage biopharma Cytokinetics increased following positive comments from an Needham analyst.
Humana, pharma stocks sink as healthcare is worst performing sector wednesday
Shares of Omeros fell almost 10% after analysts' downgraded the biotech.
Today's Perilous Reversal Stock: Keryx Biopharmaceuticals (KERX)
Trade-Ideas LLC identified Keryx Biopharmaceuticals (KERX) as a "perilous reversal" (up big yesterday but down big today) candidate
Insider Trading Alert - CFFI, KERX And INCY Traded By Insiders
Stocks with insider trader activity include CFFI, KERX and INCY
Keryx Biopharmaceuticals (KERX) Marked As A Dead Cat Bounce Stock
Trade-Ideas LLC identified Keryx Biopharmaceuticals (KERX) as a "dead cat bounce" (down big yesterday but up big today) candidate
Keryx biopharmaceuticals (kerx) stock continues to fall on disrupted production
Keryx Biopharmaceuticals (KERX) stock is still declining Tuesday afternoon after the company's only approved medication experienced disruptions in production.
3 Stocks Underperforming Today In The Drugs Industry
TheStreet highlights 3 stocks pushing the drugs industry lower today.
Why keryx biopharmaceuticals (kerx) stock is plummeting today
Keryx Biopharmaceuticals (KERX) stock is trading sharply lower on a disruption to the production of its only approved medication.
Bed, Bath & Beyond Stock Plummets As Ryan Cohen Nets $60 Million From Activist Exit
GameStop chairman Ryan Cohen completed his exit from an activist stake in Bed, Bath & Beyond Thursday after riding a meme-lead rally to a near $60 million in profits.
Home Depot Stock Gains On $15 Billion Buyback, $1.90 Dividend; Ted Decker Named Chairman
Home Depot closed out a busy week by naming CEO Ted Decker as chairman, unveiling a new $15 billion buyback and declaring a $1.90 per share dividend.
Applied Materials Stock Lower After Q3 Earnings, Chip Market Caution
"Although we're confident in our ability to perform well in a range of market scenarios, we're mindful of the current macroeconomic trends," said CEO Gary Dickerson.
Deere Stock Tumbles As Supply Chain Pressures Bring Q3 Earnings Miss, Profit Forecast Cut
Deere's third quarter profits "reflected higher costs and production inefficiencies driven by the difficult supply-chain situation," said CEO John May.